Health X Platform Limited
NSE: HEALTHXINE019J01013(was SASTASUNDR)·Healthcare·www.healthxplatform.com ↗·Mcap ₹927 Cr·Listed 2010
₹288.65▼ ₹2.00  (−0.69%)
52W: ₹253 – ₹363 · Vol: 9.3K shares · Close 25 Sept
Set Alert

Quarterly results

consolidated · as filed with NSE · Q1 FY27 back to Q4 FY18
₹ croreQ1 FY27Q4 FY26Q3 FY26Q2 FY26Q1 FY26Q4 FY25Q3 FY25Q2 FY25Q1 FY25Q4 FY24Q3 FY24Q2 FY24Q4 FY23Q3 FY23Q2 FY23Q1 FY23Q3 FY22Q2 FY22Q1 FY22Q4 FY21Q3 FY21Q2 FY21Q1 FY21Q4 FY20Q3 FY20Q3 FY19Q2 FY19Q1 FY19Q4 FY18
Revenue from operations44737434630129828628127427030737435831328125419214315917313313714213611610355.553.949.746.7
Other income12.813.813.65.525.421.6−11.822.327.718.520.19.78.745.85.12.63.810.61.20.610.71.6110.20.5
Total expenses45840135832529431230628027432037435832729326321015717018014214214513813211866.662.65853.4
EBITDA−8.4−25.2−10.4−22.66.1−25.2−23.7−4.7−2.4−10.63.43.4−11.2−10.1−6.3−16.4−13.3−10−5.1−7.8−3.4−2.5−0.6−16.1−12.5−9−6.7−6.4−5.1
EBITDA margin-1.9%-6.7%-3.0%-7.5%2.0%-8.8%-8.4%-1.7%-0.9%-3.5%0.9%0.9%-3.6%-3.6%-2.5%-8.5%-9.4%-6.3%-2.9%-5.9%-2.5%-1.7%-0.4%-13.9%-12.1%-16.2%-12.4%-12.9%-10.9%
Finance costs0.60.50.200.100.10.10.10.30.20.20.30.30.30.10.50.60.40.20.30.30.2−0.40.20.60.50.40.2
Depreciation1.91.92.21.31.21.31.41.51.62.52.32.22.82.41.81.21.1111.11.111.30.71.41.51.61.51.5
Profit before tax2−14.80.9−18.630.2−4.6−39.2−17424.652110.6−5.6−8.7−10.5−12.51,157−7.8−5.5−8.5−3.6−3.1−1.1−15.7−12.3−10.1−7.8−8.1−5.1
Tax−0−1.90.6−3.23.6−22.20.8−22.9−25.3−29.20.8−2.516.1−0.2−23.6−113310.800.10.40.1−0.2−00.40.20.20.1
Net profit2−130.4−15.426.617.6−37.8−1554121.6−3.2−12.2−48−32.4−7.9−25.21,024−8.8−6.3−8.6−3.8−3.6−1.2−15.4−12.3−9.2−6.9−7.4−4.2
Net margin0.4%-3.5%0.1%-5.1%8.9%6.1%-13.4%-56.6%15.2%7.0%-0.9%-3.4%-15.3%-11.5%-3.1%-13.1%717.9%-5.5%-3.6%-6.4%-2.8%-2.5%-0.9%-13.3%-11.9%-16.5%-12.9%-15.0%-9.1%
EPS (₹)0.80-3.510.35-3.997.524.30-8.47-34.409.795.17-0.23-2.55-10.75-7.36-1.55-6.24232.31-1.43-1.14-1.90-0.63-0.70-0.04-3.06-2.69-2.88-2.18-2.34-1.33
Net profit YoY−92.5%−173.8%+101.0%+90.0%−35.1%−18.5%−1070.2%−1168.4%–+144.9%+90.0%−53.5%–−103.2%+9.2%−300.9%+27183.9%−144.5%−433.2%+44.5%+69.2%–––−34.0%––––

Annual results

financial years ending March · from the fourth-quarter filings
₹ croreFY26FY25FY24FY23FY21FY20FY18
Revenue from operations1,3191,1111,3761,040548385159
Other income58.359.860.423.63.43.12.6
Total expenses1,3791,1731,3801,093568446181
EBITDA−52.1−565.4−44−14.3−55.4−15.4
EBITDA margin-4.0%-5.0%0.4%-4.2%-2.6%-14.4%-9.7%
Finance costs0.80.210.910.70.5
Depreciation6.65.89.18.24.54.95.5
Profit before tax−2.4−19355.7−37.4−16.4−57.6−12.4
Tax−0.9−70.1−36.4−22.80.7−5.42.4
Net profit−1.4−1345.9−99.5−17.1−52.1−11.9
Net margin-0.1%-12.0%0.4%-9.6%-3.1%-13.5%-7.5%
EPS (₹)0.37-28.662.79-22.70-3.27-12.20-3.73
Net profit YoY+98.9%−2381.8%+105.9%–+67.2%––
EPS is as filed for each period and is not restated for later bonus issues or splits.

Cash flow

annual · ₹ crore
₹ croreFY26FY25FY24FY23
Operating cash flow−73.8−17.338.2−104
Investing cash flow171−1.1−33.9124
Financing cash flow−79.6−0.4−2.4−0.9
Capital expenditure14.910.414.227.9
Free cash flow (CFO − capex)−88.8−27.723.9−132

Net profit trend

annual, ₹ crore
FY20
₹−52.1
FY21
₹−17.1+67%
FY23
₹−99.5−482%
FY24
₹5.9+106%
FY25
₹−134−2382%
FY26
₹−1.4+99%

Result filings

as filed with NSE · PDF and XBRL
PeriodBasisFiledDocuments
Q1 FY27Consolidated7 Aug 2026PDF on NSE XBRL
Q1 FY27Standalone7 Aug 2026PDF on NSE XBRL
Q4 FY26Consolidated · audited30 May 2026PDF on NSE XBRL
Q4 FY26Standalone · audited30 May 2026PDF on NSE XBRL
Q3 FY26Consolidated6 Feb 2026PDF on NSE XBRL
Q3 FY26Standalone6 Feb 2026PDF on NSE XBRL
Q2 FY26Consolidated13 Nov 2025 PDF XBRL
Q2 FY26Standalone13 Nov 2025 PDF XBRL
Q1 FY26Consolidated12 Aug 2025 PDF XBRL
Q1 FY26Standalone12 Aug 2025 PDF XBRL

Annual reports

NSE archive
Key ratios
P/E (TTM)5Y avg 165.1×-35.2×
P/B5Y avg 1.08×1.43×
ROEFY26, on average equity-0.2%
Net margin-0.1%
Debt / equity0.03×
Revenue CAGR (3Y)8.3%
Profit CAGR (3Y)–
EPS (TTM)₹-8.19
Market cap₹918 Cr
Computed from the filings and the last close. Market cap uses the latest share count from the balance sheet.
P/B vs history
1.43×
vs 9-point avg 1.08× (+33%)
0.71× low1.08× avg1.43× high
History points are balance-sheet dates (2021 → 2026), priced at the adjusted close on each date.
Balance sheet 31 Mar 2026
Total assets₹936 Cr−4%
Net worth₹641 Cr−4%
Total borrowings₹22 Cr
Cash & bank balances₹30 Cr+143%
Investments₹519 Cr−10%
Inventories₹145 Cr+31%
Trade receivables₹8 Cr−23%
Change vs the same date a year earlier.
Revenue mix FY26
Healthcare Network97.3%result ₹−66.6 Cr
Others1.7%result ₹1 Cr
Financial Services1.0%result ₹10.7 Cr
Segment revenue as reported, before inter-segment eliminations.
Shareholding 30 Jun 2026
%Jun 26Mar 26Dec 25Sept 25Jun 25Mar 25Dec 24Sept 24Jun 24Mar 24Dec 23Sept 23
Promoter74.0774.8474.6974.2474.2474.1173.9473.9273.9273.9273.9273.92
FII2.292.172.252.041.881.601.710.990.610.560.490.32
DII2.602.602.072.072.092.061.851.981.350.960.860.17
Retail11.9512.2512.7112.8413.3513.7014.0914.4715.0516.0616.5215.64
Other public9.098.148.288.818.448.538.418.649.078.508.219.95
11,502 shareholders · NSE shareholding pattern filings.